ArticleBritish journal of cancer2020

Imatinib in combination with phosphoinositol kinase inhibitor buparlisib in patients with gastrointestinal stromal tumour who failed prior therapy with imatinib and sunitinib: a Phase 1b, multicentre study.

Hans Gelderblom et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.